Literature DB >> 32811622

Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use.

R Kathryn McHugh1, Victoria R Votaw2, Nadine R Taghian3, Margaret L Griffin4, Roger D Weiss4.   

Abstract

OBJECTIVE: Benzodiazepines are among the most commonly misused drugs. Despite the known risks of combining benzodiazepines and alcohol, little is known about misuse among people with alcohol use disorder (AUD). Our aim was to characterize the prevalence, correlates, and patterns of misuse of benzodiazepines in adults with AUD.
METHOD: Adults receiving treatment for AUD (N = 258) completed a battery of questionnaires. We used descriptive statistics to characterize the prevalence and patterns of misuse and we used logistic regression models to identify correlates of misuse.
RESULTS: Almost half of the sample reported a history of benzodiazepine prescription and 30% reported a history of misuse. Younger age, female sex, anxiety, and other substance use were associated with misuse. Coping was the most commonly reported reason for misuse. All participants who had misused a benzodiazepine in the past year used concurrently with another substance.
CONCLUSIONS: Benzodiazepine misuse was common in this study, and risky patterns of use, such a co-use with other substances, were prevalent. Coping was the most common reason for misusing benzodiazepines, suggesting that un- or under-treated psychiatric symptoms may contribute to misuse.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol use disorder; Anxiety; Benzodiazepines; Polysubstance use

Mesh:

Substances:

Year:  2020        PMID: 32811622      PMCID: PMC7438601          DOI: 10.1016/j.jsat.2020.108061

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  25 in total

1.  Sedative use and misuse in the United States.

Authors:  Renee D Goodwin; Deborah S Hasin
Journal:  Addiction       Date:  2002-05       Impact factor: 6.526

2.  Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; David A Fiellin; Marilyn Byrne; Hilary S Connery; William Dickinson; John Gardin; Margaret L Griffin; Marc N Gourevitch; Deborah L Haller; Albert L Hasson; Zhen Huang; Petra Jacobs; Andrzej S Kosinski; Robert Lindblad; Elinore F McCance-Katz; Scott E Provost; Jeffrey Selzer; Eugene C Somoza; Susan C Sonne; Walter Ling
Journal:  Arch Gen Psychiatry       Date:  2011-11-07

3.  Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders.

Authors:  Victoria R Votaw; Katie Witkiewitz; Linda Valeri; Olivera Bogunovic; R Kathryn McHugh
Journal:  Addict Behav       Date:  2018-08-14       Impact factor: 3.913

4.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

5.  Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Boji Huang; Deborah A Dawson; Frederick S Stinson; Deborah S Hasin; W June Ruan; Tulshi D Saha; Sharon M Smith; Risë B Goldstein; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-07       Impact factor: 4.384

6.  Increasing Benzodiazepine Prescriptions and Overdose Mortality in the United States, 1996-2013.

Authors:  Marcus A Bachhuber; Sean Hennessy; Chinazo O Cunningham; Joanna L Starrels
Journal:  Am J Public Health       Date:  2016-02-18       Impact factor: 9.308

7.  The nature of benzodiazepine dependence among heroin users in Sydney, Australia.

Authors:  J Ross; S Darke
Journal:  Addiction       Date:  2000-12       Impact factor: 6.526

8.  Treatment or "high": benzodiazepine use in patients on injectable heroin or oral opioids.

Authors:  Marc Vogel; Bina Knöpfli; Otto Schmid; Mari Prica; Johannes Strasser; Luis Prieto; Gerhard A Wiesbeck; Kenneth M Dürsteler-Macfarland
Journal:  Addict Behav       Date:  2013-05-22       Impact factor: 3.913

9.  Expectations and motives for substance use in schizophrenia.

Authors:  K T Mueser; P Nishith; J I Tracy; J DeGirolamo; M Molinaro
Journal:  Schizophr Bull       Date:  1995       Impact factor: 9.306

10.  Patterns in Outpatient Benzodiazepine Prescribing in the United States.

Authors:  Sumit D Agarwal; Bruce E Landon
Journal:  JAMA Netw Open       Date:  2019-01-04
View more
  2 in total

1.  Sexual minority disparities in opioid and benzodiazepine misuse among adults with opioid use disorder.

Authors:  Cara A Struble; Kathryn Thomas; Madeline R Stenersen; Kelly E Moore; Catherine Burke; Brian Pittman; Sherry A McKee
Journal:  Am J Addict       Date:  2022-03-03

2.  Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance.

Authors:  Andrew J Melaragno
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-06-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.